diffuse parenchymal lung disease
Conditions
Interventions
None listed
Sponsors
Kanagawa Cardiovascular and Respiratory Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients who received transbronchial cryobiopsy.
Exclusion criteria
Exclusion criteria: Patients who cannot acquire a agreement of participation in this cohort study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of transbronchial cryobiopsy on diagnosis of diffuse parenchymal lung disease | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse event and mortality | — |
Countries
Japan
Contacts
Public ContactTakashi Niwa
Kanagawa Cardiovascular and Respiratory Medicine Department of Respiratory Medicine
Outcome results
None listed